Psychiatric Medications Flashcards
Anti-depressants
- Common mechanism of action
- Common time needed
Anti-depressants
- Common mechanism of action
- Common time needed
- Serotonin activity
- increase activity at post-synaptic receptor - 2-3 weeks
SSRIs
- Mechanism
SSRIs
- Mechanism
- Reduce pre-synaptic uptake
- Increased junction serotonin
- Down-regulation of post-synaptic receptors
SSRIs
- ADRs
- Short term
- Sensitive
- Uncommon
SSRIs
- ADRs
- Short term
- restlessness/agitation
- GI/Nausea
- Headache - Weight change
- Sexual dysfunction
- low libido
- failure to orgasm - Less common
- Bleeding (eg. PPI with aspirin)
- Suicidal ideation
(Young men, first few weeks)
SSRIs
- 4 commonest (dose)
- Choosing
SSRIs
- Commonest & Use
- Sertraline (50-200)
- Safe in heart disease - Citalopram (20-40)
- QTc prolongation
- Escitalopram (10-20) - Fluoxetine (20-60) (prozac)
- Serotonin syndrome when switching - Paroxetine (20-60)
- Discontinuation syndrome
SNRIs
- Mechanism
- Uses
SNRIs
- Mechanism
1. Reduce pre-synaptic uptake
2. Increased junction serotonin (and NA)
3. Down-regulation of post-synaptic receptors - Uses
1. Evidence for neuropathic pain
2. Similar to SSRIs
SSRIs vs SNRIs
- Effects
SSRIs vs SNRIs
- Effects
SNRI
1. Greater sedation
2. Greater Nausea
3. Greater Sexual dysfunction
SNRIs
- 2 examples (doses)
- ADRs
SNRIs
- 2 examples (doses)
- ADRs
- Duloxetine (60-120mg)
- Venlafaxine (75-375mg)
- More efficacious
- Higher dose tolerated
- Caution in heart disease (BP)
Mirtazepine
- Mechanism
- Activity and ADRs
Mirtazepine
- Mechanism
1. NaSSA - NA and Serotonin
2. 5HT-2 and 5HT-3 antagonist - Activity and ADRs
1. Strong H1 activity - sedation
- Weight gain
Tricyclic Antidepressants
- ADRs
Tricyclic Antidepressants
- ADRs
- Muscarinic
- Histaminic
- Overdose
- QTc prolongation
- Arrythmias
MAOIs
- Types
- Examples (reversible/irreversible)
- ADRs
MAOIs
- Types
1. MAOi - A - More serotonin
2. MAOi - B - More on dopamine
- Examples
1. Reversible - Moclobamide
- Tranylcypromine
- Irreversible
- Phenelzine
- Isocarboxazid
- ADRs
1. Serious interactions
- Tyramine reaction
- HTN crisis
- Avoid tyramine foods (cheese, pickled meats, wine) - 6 week washout period before new AD
Vortioxetine
- Effects
- ADRs
Vortioxetine
- Effects
1. Serotonergic
2. Antagonism and agonism - ADRs
1. Few side effects
2. Less nausea
3. Less cognitive symptoms
ADs
- Dose changing
ADs
- Dose changing
- Depression
- If no effect, switch, don’t increase - Anxiety
- If no effect, consider increasing - ADRs
- May improve in 2 weeks
- Consider switching if problem
Discontinuation syndrome
- Character
- Causes
Discontinuation syndrome
- Character
1. Shakes,
2. Agitation, insomnia
3. Headaches, N&V
4. Paresthesia, clonus - Causes
1. Short half lives
2. Paroxetine & Venlafaxine - Slow taper
- Consider Fluoxetine cover
Serotonin syndrome
- Cognitive
- Autonomic
- Somatic
- Treatment
Serotonin syndrome
- Cognitive
1. Headaches, agitation
2. Hypomania, confusion
3. Coma - Autonomic
1. Shivering, sweating
2. Hyperthermia, tachycardia
3. N&D - Somatic
1. Myoclonus, hyper-reflexia
2. Tremor - Treatment
0. Stop treatment
1. Fluids
2. Monitoring
3. Seizure Meds
Antipsychotics
- Effects
- Pathways
- Unwanted pathways
- ADRs
Antipsychotics
- Effects
1. D2 receptors - Pathways
1. Mesocortical
2. Mesolimbic - Unwanted pathways
1. Nigrostriatal
2. Tuberoinfundibular (HPA) - ADRs
1. Sedation
2. Extra-pyramidal
3. Weight gain
- Acurte dystonia
- Oculogyric crisis
Antipsychotics
- Typical vs Atypical
- ADRs, receptors
Antipsychotics
- Typical
1. Extrapyramidal
2. Muscarinic
3. Histaminic - Atypical
1. Serotenergic
Antipsychotics
- 5 Typicals
- 5 Atypicals
Antipsychotics
- 3 Typicals
- Haloperidol
- Chlorpromazine
- Flupenthixol
- 5 Atypicals
1. Clozapine
2. Olanzapine
3. Risperidone
4. Quetiapine
5. Aripiprazole - D2 partial agonist
- No QTC
Tardive dyskinesia
- Signs
Tardive dyskinesia
- Signs
- Involuntary mouth movements
- Chewing
- Tongue movements - Sometimes throat
Akathisia
- Signs
Akathisia
- Signs
- Involuntary movements
- Especially leg movements
Antipsychotic monitoring
- Baseline
- Weekly
- Three months
- Yearly
Antipsychotic monitoring
- Baseline
- HR & BP
- Weight, ECG
- FBC, Lipids, LFT, HbA1C - Weekly
- Weight - Three months
- As baseline - Yearly
- As baseline
Clozapine
- Discovery
- Withdrawal
- Mechanism
Clozapine
1.Discovery
- 1958, used 60s
- Withdrawal
- 1975 - Mechanism
- D2, 5HT-2 antagonist
Clozapine
- Indication
- ADRs
- Monitoring
Clozapine
- Indication
1. Schizophrenia
2. After 2 others - ADRs
1. Agranulocytosis 1% - 3% neutropenia
2. Gastrointestinal hypomobility - Valproate
3. Seizures - Baseline
0. BMI, ECG, HR, BP
1. FBCs
2. U&E, LFT, Trop, and Prolactin - FBC
1. Weekly to 18 weeks
2. Fortnightly from 18 weeks
3. Monthly from 1 year
Neuroleptic malignant syndrome
1. Trigger
2. S&S
3. Mx
Neuroleptic malignant syndrome
- Trigger
- High potency antipsychotics
- Antipsychotic naive
- High dose - S&S
- Fever, sweating
- Confusion
- Muscle rigidity
- Autonomic instability
- Rhabdo/renal failure, seizures - Mx
- ED
- Stop antipsychotics
- Fluids, anti-pyrexial
Extra-pyramidal ADRs
- Mx
- Dx ADRs
Extra-pyramidal ADRs
- Mx
- Nigrostriatal pathway
- Dopamine: ACh - Anticholinergics
- Procyclidine
(Benzatropine/trihexphenidyl)
- ADRs of Tx
- Tardive dyskinesia
Anxiety
- Tx (Drugs)
Anxiety
- Tx (Drugs)
- Beta blockers
- Benzos
- ADs
- Pregabalin
Benzos
- Common half lives
- Mechanism
- Max use
Benzos
- Common half lives
1. Longer - Diazepam
2. Shorter - Lorazepam - Mechanism
1. Positive allosteric modulator of GABA
2. Bind to receptor and reduce excitability - Max use
1. 6 Weeks
Paradoxical disinhibition
- Drug
- Effect
Paradoxical disinhibition
- Drug
- Benzos - Effect
- Increased agitation
- At low doses
Pregabalin
- Mechanism
- Indications
- Abuse
Pregabalin
- Mechanism
1. GABA synthesis catalyst - Indications
1. Anxiety
2. Neuropathic pain
3. Epilepsy - Abuse
1. Dependence
2. Sedation
3. CNS depressant
ADs in Anxiety
- Groups
- OCD
ADs in Anxiety
- Groups
1. SSRIs
- OCD
2. High doses required
Psych Hypnotics
- Types
- Use
Psych Hypnotics
- Types
1. Benzos (potent) - Temazepam
- Lormatazepam
- Nitrazepam
- Non-benzos
- Z Drugs
- Zopiclone, Zolpidem
- Use
1. 5-7 days
2. Two weeks only - Rebound insomnia
Lithium
- Mechanism
- Monitoring
- Indication
- Instructions
- Common ADRs
Lithium
- Mechanism
1. Unknown
2. NA release reduced
3. Serotonin synthesis - Monitoring
1. Narrow window
2. Kidney excretion - Indication
1. Mood stabilisation
2. Augment ADs
-Instructions
1. Plenty of water
2. Same time daily
- better at night
- record in book
3. Don’t stop suddenly
- Talk to doctor about changing dose
4. Leave missed dose
- Common ADRs
1. Polydipsia/polyuria
2. Fatigue
3. Weight gain
4. Fine tremor
Lithium
- ADRs
Lithium
- ADRs
SEs
1. GI
2. Taste
3. Fine tremor
4. Polydipsia/polyuria
5. Weight gain
Long-term
1. Hypothyroid
- Anual TFTs
2. Renal
- Irreversible impairment
- Anual U&Es
Lithium
- Toxicity
- Interactions
- Mx
Lithium
- Toxicity
0. Dehydration
1. Confusion, coarse tremor
2. N&V
3. Ataxia and seizures - Interactions
1. NSAIDs
2. Loop Ds
3. ACEis - Mx
1. Hydration
2. Fluids
3. Dialysis
Bipolar
- Use of S-G APs
Bipolar
- Use of S-G APs
- Quetiapine First Line
- Better SE profile than Li - FGAs have effect too
AEDs as mood stabilisiers
- Action
- Common choices
- ADR and monitoring
AEDs as mood stabilisiers
- Action
1. GABA
2. Ca&Na - Common choices
1. Valproate (LFTs)
2. Carbamazepine
3. Lamotrigine (SJS)
4. Pregabalin - ADR and monitoring
1. Thrombocytopenia (FBC)
2. Sedation
3. Weight gain
Dementia
- Types
- Drugs
- ADRs
Dementia
- Pharmacy
- Acetylcholinesterase
- Donepezil
- Galantamine
- Rivastigmine
- Good for apathy
- Mild to moderate only - ADRs
- DNV, cramps
- Insomnia, anorexia,
- NMDA antagonist (glutamine)
1. Memantine - Moderate-severe Alzheimers
2. Agitated behaviour
3. ADRs - Headache, nausea
- Drowsiness, insomnia
ADD and ADHD
- Classes
- ADRs
ADD and ADHD
- Stimulants
1. Methylphenidate
2. Dextroamphetamine
3. Monitor weight and height - NA re-uptake inhibitor
1. Atomoxetine
2. Used in previous dependence
Depression first line meds
- CAMHS
- Adult
- Older persons
Depression first line meds
- CAMHS
1. Fluoxetine - Adult
2. SSRIs - Older persons
3. SSRIs and monitor sodium
Clozapine counseling
- Common side effects
Clozapine counseling
- Common side effects
- Sedation
- May improve with time
- Consider night time dosing - Constipation
- Bowel monitoring
- High fibre
- Stimulant laxatives - Tachycardia
- Cardiology advice/ BBs - Weight gain
- Dietary advice/Metformin - Hypersalivation
- Improve with time
- Hyoscine - BP (either)
- Hyperglycaemia
- Tablets or insulin
Lithium toxicity
- S&S
Lithium toxicity
- S&S
- Confusion and drowsiness
- Visual disturbance
- Loss of appetite
- Difficulty speaking
- Seizures
- Excessive thirst/urination
LITHIUM
- Mnemonic
LITHIUM
- Mnemonic
L - lethargy
I - Insipidus (DI)
T - Tremor
H - Hypothyroidism
I - Insides (GI)
U - Urine
M - Metallic taste
Lithium counseling
- Pregnancy
Lithium counseling
- Pregnancy
- Evidence not entirely clear
- First trimester
- Birth defects increased - Fetal heart defect increased
- Breastfeeding
- Not safe - Contraception
- Sub Dermal
- IUS
- Birth defects
Extrapyrimidal SEs
- Timeline
- Hours
- Days to weeks
- Months
- Years
Extrapyrimidal SEs
- Timeline
- Hours
- Acute dystonia
Eg. Eye movements - Days to weeks
- Bradykinesia
Eg. Slowing - Months
- Akathisia
Eg. Jumping out of skin - Years
- Tardive dyskinesia
Eg. Tongue or lip smacking
Dopaminergic effects
- Prolactin pathway
Dopaminergic effects
- Prolactin pathway
- Tuberoinfundibular
Anti-HAM SEs
Anti-HAM SEs
H- histaminergic
1. Sedating
A - Alpha adrenergic
1. Ortho hypertension
2. Arrhythmia
3. Sexual dysfunction
M - muscarinic
1. Weight gain
2. Liver enzymes
3. Ophthalmic
4. Dermatology
5. Seizures
Bipolar antidepressant
Bipolar antidepressant
- Quetiapine